Frank D. Vrionis, M.D., M.P.H., PhD, Chief of Neurosurgery at the Marcus Neuroscience Institute

Summary

---

Podcast Summary: Becker’s Healthcare Podcast

Guest: Frank D. Vrionis, M.D., M.P.H., PhD, Chief of Neurosurgery, Marcus Neuroscience Institute

Host: Carly Beam

Date: December 7, 2025

---

Overview

In this episode, Dr. Frank Vrionis, a globally-trained neurosurgeon and Chief of Neurosurgery at the Marcus Neuroscience Institute, discusses the evolving landscape of healthcare, focusing on technology-driven innovations in neurosurgery and spine care. Key topics include the integration of artificial intelligence (AI) into medical practice, the prospects and challenges of motion-preserving spine surgery, and the increasing impact of insurance dynamics on access to care and innovation.

---

Key Discussion Points & Insights

Dr. Vrionis’ Background

• Dr. Vrionis recounts his extensive medical training across Greece, Harvard, Duke, and Tufts, and his prior leadership at USF and Moffitt Cancer Center before joining Marcus Neuroscience Institute.
  • "I've been practicing for many years. I did my medical school in Athens, Greece. My Master of Public Health at Harvard, my PhD at Duke, and my residency in neurosurgery at Tufts Medical Center." [00:26]

---

Major Trends in Healthcare

Highlighted Trends:

• Efficiency of healthcare delivery (particularly through AI)
• Technological innovation
• Research advancements

On the Strengths & Weaknesses of the System:

• "There’s no healthcare system that's perfect. So it's important to try, even in small ways, to improve on the current one." [02:19]

---

Integration of AI in Neurosurgery

• Current Use: AI as a research tool for building anatomical models of the spine using imaging data (CT/MRI), offering biomechanical insights pre-surgery.
  • "We've developed an AI software...the AI can deliver for us a computer model of somebody's spine...and we can potentially ask questions from a biomechanical standpoint, like if we do this intervention, what will happen to the spine?" [03:10–03:24]
• Potential & Future Vision:
  • Application in patient communication (automating responses to routine queries)
  • Data analytics (billing, scheduling, insurance)
  • Diagnostic aids (imaging analysis)
  • "AI has the potential to analyze very quickly a lot of data and respond to things much faster than a human can." [05:26]

---

Growth & Innovation at Marcus Neuroscience Institute

• People & Technology: Expansion through hiring specialists (neurology, neurosurgery, pain management) and adopting emerging technologies (robotics, augmented reality, advanced research).
  • "Growth is through people, but also through new technologies—robotics, augmented reality, and research." [06:48–07:23]
• Philanthropic Funding: Crucial support from the Marcus Foundation has enabled ongoing research into brain tumors, drug delivery, and spine conditions.

---

Exciting Advances in Spine Neurosurgery

• Motion Preservation Technology:
  • A shift from traditional spinal fusion (which often leads to adjacent segment disease and loss of mobility) to newer alternatives like disc and facet joint replacements.
  • "Motion preservation in the sense of disc replacement as well as facet replacement...can restore the motion segment and prevent this domino effect that we see with fusions..." [09:52]
• Clinical Realities: Young patients especially benefit from motion-preserving approaches, but insurance coverage remains a significant barrier.
  • "A lot of insurance companies...consider it experimental, despite the fact that there's like decades of research and...everything that we use is FDA approved." [10:38]
  • "You don't want to have 30 year olds with fusions because then inevitably they're going to have more issues down the road." [11:21]
• Patient Selection Remains an Art: Adopting new techniques requires nuanced, individualized judgment.
  • "It's an art and not a science...we're still learning about how we effectively can utilize these type of technologies." [12:09]

---

The Challenge of Insurance & Cost in Healthcare

• Key Disruptor for 2026: Dr. Vrionis predicts the rising costs of healthcare products and insurance, along with new technology pricing and coverage denials, will severely hamper innovation and patient care.
  • "Pricing of new technologies or new products, lack of insurance coverage, denials by insurance and affordability of health care...are the potential disruptors that I see that can curtail innovation..." [13:11]
  • "Physicians are in the practice of medicine because they like what they do. But we constantly have to shape what we do and fight for what we believe with a lot of other stakeholders..." [14:21]
• Impact on Physicians: Increasing administrative burdens and third-party decision-making have changed the practice environment.
  • "It was not like that when I first practiced medicine...Now this is peer reviews, peer to peer...Denials, things like that are going to be obstacles..." [14:36]

---

Strategies Amidst Industry Headwinds

• Limited Levers for Physicians: Most insurance and pricing decisions remain out of the hands of practitioners.
  • "We really cannot strategize on those things because they're beyond our controls..." [15:19]
• Focus on Patient Education:
  • Ensuring patients are informed about their options, especially as many are only presented with one (often suboptimal) choice.
  • "What we can do is educate patients about the type of technologies we have now and provide patients with options...a lot of patients are uninformed." [15:48]

---

Notable Quotes & Memorable Moments

• On AI’s Potential:
  • "AI has the potential to analyze very quickly a lot of data and respond to things much faster than a human can." – Dr. Vrionis [05:26]
• On Motion Preservation vs. Fusion:
  • "You don't want to have 30 year olds with fusions because then inevitably they're going to have more issues down the road." – Dr. Vrionis [11:21]
• On Insurance Obstacles:
  • "[Insurance companies] consider it experimental, despite the fact that there's like decades of research and...everything that we use is FDA approved." – Dr. Vrionis [10:40]
• On Challenges in Healthcare Delivery:
  • "Physicians...constantly have to shape what we do and fight for what we believe with a lot of other stakeholders...in order to get the maximum benefit for the patient." – Dr. Vrionis [14:21]
• On Physician Strategy:
  • "We really cannot strategize on those things because they're beyond our controls..." – Dr. Vrionis [15:19]

---

Timestamps for Important Segments

• Background & Career Journey: [00:18–01:13]
• Top Trends in Healthcare: [01:31–02:25]
• AI in Clinical Practice & Research: [02:49–05:26]
• Institute Growth & Technology: [06:34–07:52]
• Motion Preservation & Challenges: [08:14–12:09]
• Key Disruptors: Insurance & Cost: [12:26–15:08]
• Strategies & Patient Education: [15:08–16:07]

---

Tone & Style

Dr. Vrionis speaks candidly and with measured optimism, balancing enthusiasm for innovation with a pragmatic understanding of the systemic obstacles facing both clinicians and patients. The emphasis is on thoughtful integration of technology and the persistent challenges of insurance and healthcare costs.

---

This summary encapsulates the primary themes, innovations, hurdles, and forward-looking perspectives from Dr. Vrionis, offering a concise yet thorough understanding of the episode for those unable to tune in.

Transcript

[A]

This is Carly Beam with the Beckard Spine and Orthopedics podcast. And today I'm thrilled to be joined by Dr. Frank Veronis, Chief of neurosurgery at the Marcus Neuroscience Institute. Dr. Varonis, thank you so much for being here today.

[B]

Thank you, Carly. Pleasure to be here.

[A]

And so, Dr. Varunos, before we dive into questions, can you introduce yourself and share more about your background?

[B]

Sure. So I'm Frank Veronis. I'm a neurosurgeon. I have been practicing for many years. I did my medical school in Athens, Greece. My Master of Public Health at Harvard, my PhD at Duke, and my residency in neurosurgery at Tufts Medical Center. I, prior to coming here to Boca Raton, I was for 16 years at USF and Moffitt Cancer center, where I also served as chief of neurosurgery. That's in a nutshell.

My synopsis of my life so far.

[A]

That's a great, impressive background you have. It looks like just from all over the world as well. And I'm wondering, Dr. Varonis, what are the top three trends that you're following in healthcare today?

[B]

Yeah, certainly. I mean, I'm interested in.

Healthcare as a general rule, but in particular, things that can help with the efficiency of delivery of the health care, such as AI. That's one thing. Also technology innovations.

And also research. There are some of the things that I would be interested in and the strengths and the weaknesses of the system. As you know, there's no healthcare system that's perfect. So it's important to try.

Even in small ways to improve on the current one.

[A]

Absolutely. You touched on some really big things going on here. You mentioned healthcare delivery, AI and research. I wanted to hone in a bit. I'd love to hear how you're using AI in your practice. I know a lot of spine surgeons I've talked to. They've shared just the various ways it's helped them both in the clinical office setting with surgery itself. I'd love to hear your perspective.

[B]

I mean, AI from my perspective right now is only a research tool. We've developed an AI software that applies to spine so that, for example, if.

Somebody, we can enter somebody's CAT scan or MRI in the system and then the AI can deliver for us.

A computer model of somebody's spine. And then we can potentially ask questions from a biomechanical standpoint, like if we do this intervention, what will happen to the spine? And so on, so forth. So from a research standpoint, that's more or Less what I have, we have, I have been involved as far as AI is concerned, but I can see that AI has a lot of other applications, potentially medicine. We see AI reading CAT scans sometimes or getting warnings about somebody's CAT scans. And I think there's also a lot of potential applications of AI, not just in data analytics, but also in.

Responses to patients questions and so on and so forth.

[A]

Definitely. That's really interesting what you're saying about research. What do you predict, like how much will AI grow in the research realm? Are you expecting?

[B]

You know, I think, I think it will grow to some degree. Now what, how exactly it's going to work and, you know, and how AI is going to be coordinated and so on is difficult really to predict. But for example, to give you some idea, we get, you know, health professionals get thousands of phone calls a day. You have to have people answering the phone. A lot of the questions, like 80% of the questions are routine and potentially AI can answer those questions. So you can have something automated, whatever, and answer those questions and only reserve, you know, a face to face, so to speak, or a person to person response for the 10, 20% of the questions that they really need, somebody who knows more about things. So just, just a very, you know, just an idea, so to speak. I see also AI being, I think already is applied in terms of, you know, billing or scheduling or many times for insurance companies as far as the mass to whether a service is appropriate or not appropriate. AI has the potential to analyze very quickly a lot of data and respond to things much faster than a human can. So there's a lot of little ways that AI can make a difference, primarily in the efficiency of healthcare delivery.

[A]

Definitely. And when you think about the Marcus Neuroscience Institute and in your department, how are you thinking about growth in the next 12 to 24 months?

[B]

Growth typically.

Happens in the sense of hiring more people to cover certain gaps that we have, maybe neurology, neurosurgery, pain management, rehabilitation, things like that. So growth is through people, but also through new technologies.

Robotics.

Augmented reality, things like that, as well as research.

We have been fortunate to receive, especially today's day, where research dollars are very difficult to find. We have been able to receive research funds from the Marcus foundation, which is a philanthropic.

Foundation. And through that we pursue research in domains such as brain tumor research.

Drug delivery, spine research, so on and so forth. So these are the areas where we see a lot of potential expansion and growth and we like to stay, stay current and on the cutting edge of things.

[A]

Yeah. Are there Are there any other spine neurosurgery technologies besides, you know, the AI that we've discussed? Are there any other technologies that really excite you?

[B]

Lately, what I've been very excited about, inspiring, especially.

Without trying to get into too many details in being esoteric, is the motion preservation technology that has been, has become part of my practice in spine on a daily basis. And as you know, in spine we have essentially two types of procedures. Just to be very simple here, simplistic. We can decompress something or free up something, or we can do reconstruct the spine. Reconstructing the spine typically has been the domain of fusions where you glue together pieces of the spine. This works in the short term, but in the long term, a lot of times people develop problems above or below their fusions because of the stresses that.

Develop.

Adjacent to a fused segment of the spine. Motion preservation in the sense of disc replacement as well as facet replacement, has been.

A thing that really can restore the motion segment and prevent this domino effect that we see with fusions and stop that particular cascade of more segments that need to be fused that lead to lack of mobility and certainly disability in the end.

[A]

Yeah, and definitely, you know, with spinal fusion, I know that's still largely considered the gold standard in spine. And then we also have the push towards motion preservation benefits. How are you in your practice?

How are you kind of balancing the benefits and needs of both in your patients?

[B]

I mean, the issue is more or less the indications as well as what can you do? Because many times our biggest problem actually with motion preservation is getting insurance approval. A lot of insurance companies, they consider it experimental, despite the fact that there's like decades of research and pretty much everything that we use is FDA approved. So when something is FDA approved, I don't know how people can claim that experimental. But insurance denials is a big obstacle to utilizing these technologies. I think especially for young people, you would like to do as much motion preservation operations instead of fusions. You don't want to have 30 year olds with fusions because then inevitably they're going to have more issues down the road. If somebody's very old and their spine is very rigid and, you know, semi fused, so to speak, then, you know, motion preservation may not be the best option there. But I think still to some degree we, you know, it's an art and not a science. I mean, to some degree, because we're still learning about how we effectively can utilize these type of technologies.

[A]

Thank you for breaking that down. My last question for you, Dr. Verones, what do you think will be a key disruptor to spine surgery and neurosurgery in 2026?

[B]

I think increasingly the biggest disruption, the biggest problem we have is coming from the insurance industry and the cost of healthcare products.

That's the biggest issue. And whether, first of all, patients can afford insurance because insurance is very expensive. Second, whether insurance will cover certain items because.

As you know, we don't have too many restrictions as to how much a new drug or a new device can cost in the U.S. you know, FDA delivers or is concerned with safety, but there's no price control. So anybody can essentially price it any way they want. So pricing of new technologies or new products, lack of insurance coverage, denials by insurance and affordability of health care.

Is the potential disruptors that I see that can curtail innovation and force us against the wall. I mean, physicians are in the practice of medicine because they like what they do. But we constantly have to shape what we do and fight for what we believe with a lot of other.

Stakeholders in the healthcare industry in order to get the maximum benefit for the patient. And that's not an easy thing, you know, and something has changed over the years. It was not like that when I first practice medicine. They didn't have to worry about those things. But now this is peer reviews, peer to peer, so to speak. Denials, things like that are going to be obstacles in the healthcare delivery because of cost primarily, and they're going to limit.

The access of the best technologies to a lot of patients.

[A]

Yeah. Dr. Reynolds, I want to just tack on one quick follow up. With all these headwinds you're describing.

How are you strategizing to get ahead of these next year?

[B]

Well, we really cannot strategize on those things because they're beyond our controls, to be honest with you. I mean, whether Aetna proves something or United approve something or doesn't approve something is impossible for us to really play any kind of role. But what we do that we can do is educate patients about the type of technologies we have now and provide patients with options. Because also what I've noticed in health care and spine in particular, is a lot of patients are uninformed.

They're only given one option, and sometimes that's not the best option for them.

[A]

Well, thank you so much for joining the podcast today, Dr. Varonis. It's been a pleasure speaking and I look forward to connecting down the line.

[B]

Thank you, Carly. I appreciate the opportunity.